Effect of combined testosterone and estradiol-17β treatment on the metabolism of E2 in the prostate and liver of noble rats

Prostate

Volumn 30, Issue 4, 1997, Pages 256-262

  Lane, Kate E ^a   Ricci, Mary Jo ^b   Ho, Shuk Mei ^a  

^a TUFTS UNIVERSITY   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

catechol estrogens; estrogen genotoxicity; estrogen metabolism

Indexed keywords

2 HYDROXYESTRADIOL; 4 HYDROXYESTRADIOL; CATECHOL ESTROGEN; ESTRADIOL; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; DYSPLASIA; ESTROGEN METABOLISM; GENOTOXICITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; RAT; RISK FACTOR;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG COMBINATIONS; ESTRADIOL; LIVER; MALE; MICROSOMES; MICROSOMES, LIVER; PROSTATE; RATS; RATS, INBRED STRAINS; TESTOSTERONE;

EID: 0030935049     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19970301)30:4<256::AID-PROS5>3.0.CO;2-J     Document Type: Article

References (32)

1. Carter BS, Carter HB, Isaacs JT: Epidemiological evidence regarding predisposing factors to prostate cancer. Prostate 16:187-197, 1990.
2. Meikle AW, Smith JA, West DW: Familial factors affecting prostatic cancer risk and plasma sex steroid levels. Prostate 6:121-128, 1985.
3. Ross R, Bernstein L, Judd H, Harisch R, Pike M, Henderson B: Serum testosterone levels in healthy young black and white men. J Natl Cancer Inst 75:45-48, 1986.
4. Zumoff B, Levin JJ, Strain GW, Rosenfeld RS, O'Connor JJ, Freed SZ, Kream J, Whitmore WS, Fukushima DK, Hellman L: Abnormal levels of plasma hormones in men with prostate cancer: Evidence toward a "2-disease" theory. Prostate 3:579-588, 1982.
5. Leav IL, Ho S-M, Ofner P, Merk FB, Kwan PWL, Damassa D: Biochemical alterations in sex hormone induced hyperplasia and dysplasia of the DLP of the Noble rat. J Natl Cancer Inst 80:1045-1053, 1988.
6. Leav IL, Merk FB, Kwan PWL, Ho S-M: Androgen supported estrogen enhanced epithelial proliferation in the prostates of intact NBL rats. Prostate 15:23-40, 1989.
7. Ho S-M, Yu M, Leav I, Viccione T: The conjoint actions of androgens and estrogens in the induction of proliferative lesions in the rat prostate. In Li JJ, Nandi S, Li SA (eds): "Hormonal Carcinogenesis." New York: Springer-Verlag, 1992, pp 18-25.
8. Noble RL: Sex steroids as a cause of adenocarcinoma in the dorsolateral prostate in Nb rats, and their influence on the growth of transplants. Oncology 34:138-141, 1977.
9. Noble RL: Production of Nb rat carcinoma of the dorsolateral prostate and response of estrogen dependent transplants to sex hormones and tamoxifen. Cancer Res 40:3547-3550, 1980.
10. Drago JR: The induction of Nb rat prostatic carcinomas. Anticancer Res 4:255-256, 1984.
11. Bosland MC, Ford H, Horton L: Induction of a high incidence of ductal prostate adenocarcinoma in NBL/Cr and Sprague Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17β or diethyl-stilbestrol. Carcinogenesis 6:1311-1317, 1995.
12. Pollard M, Luckert PH: Promotional effects of testosterone and high fat diet on the development of autochthonous prostate cancer in rats. Cancer Lett 32:223-227, 1986.
13. Pollard M, Luckert PH: Prostate cancer in the Sprague-Dawley rat. Prostate 6:389-393, 1985.
14. Ho S-M, Roy D: Sex hormone induced nuclear DNA damase and lipid peroxidation in the dorsolateral prostates of Noble rats. Cancer Lett 84:155-162, 1994.
15. Anderson J, Peck EJ Jr, Clark JH: Estrogen induced uterine responses and growth: relationship to receptor estrogen binding by uterine nuclei. Endocrinology 96: 160-167, 1975.
16. Bruchovsky N, Lesser B: Control of proliferative growth in androgen responsive organs and neoplasm. Adv Sex Horm Res 2:1-55, 1976.
17. Shaw IC, Jones HB: Mechanisms of non-genotoxic carcinogenesis. Trends Pharmacol Sci 15:89-93, 1994.
18. Cohen SM, Elwein LB: Cell proliferation in carcinogenesis. Science 240:1007-1011, 1990.
19. Liehr JG, Roy D: Free radical generation by redox cycling of estrogens. Free Rad Biol Med 8:415-423, 1990.
20. Li JJ, Li SA, Klicka JK, Parsons JA, Lam LKT: Relative carcinogenic activity of various synthetic and natural estrogens in the Syrian hamster kidney. Cancer Res 43:5200-5204, 1983.
21. Li JJ, Li SA: Estrogen induced tumorigenesis in hamsters: Roles for hormonal and carcinogenic activities. Arch Toxicol 55:110-118, 1984.
22. Li SA, Klicka JK, Li JL: Estrogen 2- and 4-hydroxylase activity, catechol estrogen formation, and implications for estrogen carcinogenesis in hamster kidney. Cancer Res 45:181-185, 1985.
23. Zhu BT, Roy D, Liehr J: The carcinogenic activity of ethinylestrogens is determined by both their hormonal characteristics and their conversion into catechol metabolites. Endocrinology 132:577-583, 1993.
24. Liehr JG, Roy D, Ulubelen AA, Bui QD, Weisz J, Strobel HW: Effect of chronic estrogen treatment of Syrian hamsters on microsomal enzymes mediating formation of catechol estrogens and their redox cycling: Implications for carcinogenesis. J Steroid Biochem 35:555-560, 1990.
25. Bui QD, Weisz J, Wrighton SA: Hepatic catecholestrogen synthases: differential effect of sex, inducers of cytochrome P-450, and of antibody to the glucocorticoid inducible cytochrome P-450 on NADPH-dependent estrogen-2-hydroxylase and on organic hydroperoxide-dependent estrogen-2/4-hydroxylase activity in rat hepatic microsomes. J Steroid Biochem Mol Biol 37:285-293, 1990.
26. Yunbo L, Trush MA, Yager J: DNA damage caused by reactive oxygen species originating from a copper-dependent oxidation of the 2-hydroxy catechol of estradiol. Carcinogenesis 15:1421-1427, 1994.
27. Henderson BE, Ross R, Bernstein L: Estrogens as a cause of human cancer: "The Richard and Hilda Rosenthal Foundation Award Lecture." Cancer Res 48: 246-253, 1989.
28. Henderson BE, Ross RK, Pike JC, Casagrande IT: Endogenous hormones as a major factor in human cancer. Cancer Res 42:3232-3239, 1982.
29. Ames BN, Gold LS: Chemical carcinogenesis; too many rodent carcinogens. Proc Natl Acad Sci USA 87:7772-7776, 1990.
30. Robinette CL, McGraw RG, Cricco RP, Mawhinney MG: Localization, metabolism and binding estrogens in the male rat. Arch Biochem Biophys 191:517-524, 1978.
31. Ofner P, Nadeau MR, Vena RL, Leav I: Metabolism of estradiol and estrone in organ cultures of dorsolateral and ventral prostate of untreated and sex-hormone implanted rats. Steroids 57:50-54, 1992.
32. Martucci CP, Fishman J: Impact of continuously administered catechol estrogens on uterine growth and luteinizing hormone secretion. Endocrinology 105:1288-1292, 1979.